Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Tinklenberg

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Rational Drug Therapy|July 1, 1975
What a physician should know about marihuanaJ R Tinklenberg
American Family Physician|November 1, 1971
A clinical view of the amphetaminesJ R Tinklenberg
Psychopharmacology Bulletin|January 1, 1983
Neuropeptides in geriatric psychopharmacologyJ R Tinklenberg, J E Thornton
Gerontology|January 1, 1981
Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary reportJ A Yesavage, J R Tinklenberg
Presse Medicale (Paris, France : 1983)|December 29, 1983
[Computerized tests of attention, memory and motor performance applied to geriatric research]J A Yesavage, J R Tinklenberg
The American Journal of Psychiatry|April 1, 1985
Olfactory deficits and primary degenerative dementiaC A Peabody, J R Tinklenberg
Psychopharmacologia|January 1, 1973
Subchronic oral doses of marihuana extractL E Hollister, J R Tinklenberg
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1974
Drug use among youthful assaultive and sexual offendersJ R Tinklenberg, K M Woodrow
Psychopharmacology|January 1, 1985
Naloxone's effect on cognitive functioning in drug-free and diazepam-treated normal humansO M Wolkowitz, J R Tinklenberg
Neuropsychobiology|January 1, 1985
A psychopharmacological perspective of cognitive functions. I. Theoretical overview and methodological considerationsO M Wolkowitz, J R Tinklenberg, H Weingartner
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Rational Drug Therapy|July 1, 1975
What a physician should know about marihuanaJ R Tinklenberg
American Family Physician|November 1, 1971
A clinical view of the amphetaminesJ R Tinklenberg
Psychopharmacology Bulletin|January 1, 1983
Neuropeptides in geriatric psychopharmacologyJ R Tinklenberg, J E Thornton
Gerontology|January 1, 1981
Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary reportJ A Yesavage, J R Tinklenberg
Presse Medicale (Paris, France : 1983)|December 29, 1983
[Computerized tests of attention, memory and motor performance applied to geriatric research]J A Yesavage, J R Tinklenberg
The American Journal of Psychiatry|April 1, 1985
Olfactory deficits and primary degenerative dementiaC A Peabody, J R Tinklenberg
Psychopharmacologia|January 1, 1973
Subchronic oral doses of marihuana extractL E Hollister, J R Tinklenberg
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1974
Drug use among youthful assaultive and sexual offendersJ R Tinklenberg, K M Woodrow
Psychopharmacology|January 1, 1985
Naloxone's effect on cognitive functioning in drug-free and diazepam-treated normal humansO M Wolkowitz, J R Tinklenberg
Neuropsychobiology|January 1, 1985
A psychopharmacological perspective of cognitive functions. I. Theoretical overview and methodological considerationsO M Wolkowitz, J R Tinklenberg, H Weingartner
Pageof 13